Keywords: salix, progresses, patient, enrollment, usa, pharmaceuticals, says

Salix progresses patient enrollment

Article | 16 January 2006

Print This

The USA's Salix Pharmaceuticals says that initial subjects have been enrolled and dosed in three late-stage trials designed to evaluate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in